SOD2 and central nervous system cancer: As shown in Table 3, four SNPs (SOD2 V16A, SOD3 T58A, GPX1 -46 C/T, and NOS1 3’-UTR) demonstrated a significant association with glioma risk, as determined by the dominant model (variant-containing genotypes versus common homozygote).